4DMT Advances 4D-710 to Phase 2 with Additional Funding and Support from the Cystic Fibrosis Foundation
Cystic Fibrosis Foundation to provide up to $11 million in additional funding to accelerate development of 4D-710 for cystic fibrosis,...
DNA
Soleno Therapeutics Appoints Biopharmaceutical Executive Mark W. Hahn to its Board of Directors
Appointment adds three decades of financial and operational leadership to Soleno’s BoardREDWOOD CITY, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) --...
Artios to Announce First Phase 1/2a Data for DNA Polymerase Theta (Polθ) Inhibitor ART6043 in Advanced Solid Tumors in Oral Presentation at ESMO
CAMBRIDGE, United Kingdom and NEW YORK, October 13, 2025 – Artios Pharma Limited (“Artios”), a biopharmaceutical company committed to realizing the...
Roche data at ESMO 2025 showcase advances in science and cancer care across multiple tumour types
Basel, 13 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it will present more than 30...
Nouscom Presents Positive Phase 2 Results of NOUS-209 Immunotherapy Combined with Pembrolizumab in MSI-H Metastatic Colorectal Cancer Patients Refractory to Anti-PD-1 Therapy, at ESMO 2025
While immune checkpoint inhibitors (anti-PD-1 +/- anti-CTLA-4) are approved as first line treatment for microsatellite instability-high (MSI-H) metastatic colorectal cancer...
Latin America Accelerates Health Data Interoperability With openEHR: A Regional Model for Global Digital Health Transformation
New Black Book Research survey reveals Brazil, Mexico, Chile, and Colombia leading rapid adoption of openEHR frameworks as Doug Brown...
New Study Showed Unnecessary Burden From Continued Monitoring of Alloimmunized Pregnancies With Antigen-Negative Fetuses
New research demonstrates that monitoring with titers frequently leads to burdensome and unnecessary monitoring for pregnancies not at risk of...
YD Bio Business Partner EG Biomed Achieves CAP Accreditation, Advancing U.S. Clinical Testing Capabilities
Taipei, Taiwan, Oct. 10, 2025 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology...
CRISPR Therapeutics Presents New Preclinical Data for CTX460™ Demonstrating In Vivo Gene Correction of Alpha-1 Antitrypsin Deficiency (AATD) Utilizing Novel SyNTase™ Editing Platform
-Preclinical data presented at the European Society of Gene and Cell Therapy (ESGCT) highlight a potential best-in-class profile- -The AATD...
Tenaya Therapeutics to Participate in H.C. Wainwright Genetic Medicines Virtual Conference
SOUTH SAN FRANCISCO, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with...
Coloplast interim CEO Lars Rasmussen will step down from the Board at the upcoming Annual General Meeting
Announcement no. 09/2025Inside information Coloplast interim CEO Lars Rasmussen will step down from the Board at the upcoming Annual General Meeting ...
CERTIFIED Opens First Columbus Dispensary, Revives Local Landmark with Drive-Thru Cannabis Experience
Ohio-born cannabis brand brings personal story, community focus, and premium products to Silver Drive locationCOLUMBUS, Ohio, Oct. 09, 2025 (GLOBE...
Genflow Biosciences PLC Announces Update on Animal Health Program
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET...
Siemens and Ducati extend partnership to advance innovation in MotoGP
Motorcycle company extends technical partnership to further integrate and optimize research and development with Siemens Xcelerator PLANO, Texas, Oct. 9,...
FIRST CANCER PATIENT SCREENED USING ELEPHAS LIVE PLATFORM AT inDNA LIFE SCIENCES in INDIA
Elephas Live™ Platform to Help Increase Access to Immunotherapy for Cancer Patients in India MADISON, Wis., Oct. 9, 2025 /PRNewswire/...
Turbine Launches Collaboration with AstraZeneca, Leveraging Turbine’s Virtual Disease Models to Rationalize ADC Discovery
LONDON, UK and BUDAPEST, HUNGARY, Oct. 9, 2025 /PRNewswire/ -- Turbine, a leading company specializing in virtualizing biological experiments with...
Telomir Pharmaceuticals Reports Discovery That Telomir-1 Selectively Kills Aggressive Triple-Negative Breast Cancer Cells
New findings show Telomir-1 shuts down cellular energy pathways and mitochondrial function in aggressive breast cancer cells, leading to cell...
Telomir Pharmaceuticals Reports Discovery That Telomir-1 Selectively Kills Aggressive Triple-Negative Breast Cancer Cells
New findings show Telomir-1 shuts down cellular energy pathways and mitochondrial function in aggressive breast cancer cells, leading to cell...
Mindfulness Meditation Apps Market Set to Surge from USD 1.2 Billion in 2024 to USD 3.2 Billion by 2033, Experiencing a Robust CAGR of 14.5% – Market Research Intellect
The growth of the Mindfulness Meditation Apps Market is primarily driven by rising global awareness of mental health and wellness,...
GenoPalate Advances Its Science Again With Diet Snapshot
MILWAUKEE, Oct. 8, 2025 /PRNewswire/ -- GenoPalate today announced Diet Snapshot, a new food frequency questionnaire inside the GenoPalate platform that...